On August 25th, BEKE-W (02423) spent 4 million US dollars to repurchase 632,900 shares.

26/08/2025

Beike-W (02423) announces that it will spend $4 million on August 25, 2025 to repurchase 63 shares...

BEKE-W (02423) announced that it will spend $4 million to repurchase 632,900 shares of stock on August 25, 2025, at a repurchase price of $6.28 to $6.42 per share.

AUSTAR (06118) released its interim performance results, with a net profit attributable to shareholders of 24.99 million yuan, an increase of 325.37% year-on-year.

I-CABLE COMM (01097) announces interim performance with a net loss of approximately HK$217 million, a year-on-year decrease of 14.95%.

Shanghai Fosun Pharmaceutical(02196): The drug registration application for Injection of Chlorhexidine Hydrochloride was accepted by the National Medical Products Administration.

AUSTAR (06118) released its interim performance results, with a net profit attributable to shareholders of 24.99 million yuan, an increase of 325.37% year-on-year.

I-CABLE COMM (01097) announces interim performance with a net loss of approximately HK$217 million, a year-on-year decrease of 14.95%.

Shanghai Fosun Pharmaceutical(02196): The drug registration application for Injection of Chlorhexidine Hydrochloride was accepted by the National Medical Products Administration.